Epidemiology: Open Access
Open Access

Economic epidemiology is a branch of epidemiology that combines economics with epidemiology. Its aim is to better understand how diseases are transmitted by including incentives for healthy behaviour and their associated behavioural reactions into an epidemiological setting. This approach could aid in improving policy responses to epidemic diseases by providing explicit tools for policymakers and health-care practitioners to consider how particular behaviours can influence disease transmission.

The theory of prevalence-dependence, or disinhibiting, which argues that people change their behaviour as the prevalence of an illness varies, was the main framework in which this area arose. The impact of externalities, global disease commons, and how people' incentives might influence the outcome and cost of health interventions are all topics covered by economic epidemiology.

Strategic epidemiology is a branch of economic epidemiology that examines the relationship between individual behaviour and population-wide disease dynamics using an explicitly game theoretic approach.

The spread of an infectious disease is a population-level phenomenon, but decisions to prevent or treat a disease are typically made by individuals who may change their behaviour over the course of an epidemic, especially if their perception of risk changes based on available epidemic information [1] their decisions will then have population-level consequences. For example, someone may choose to engage in risky sexual behaviour, or a doctor may provide medications to someone who does not have a diagnosed bacterial illness. In both circumstances, the individual's choice may be sensible, but it is undesirable from a societal standpoint.

Limiting the spread of a disease at the population level necessitates changing individual behaviour, which is dependent on the level of risk information available to them. When the risk is low, people are more likely to overlook it. Individuals are more inclined to take preventive action if the danger of infection is higher. Furthermore, the more transmissible the virus, the greater the motivation to engage in personal control [2].

Individuals may enhance their risk-taking behaviour if the risk of sickness is reduced, either through vaccination or because the disease is less prevalent. This effect is similar to the introduction of safety regulations, such as seatbelts in cars, which, because they reduce the cost of an accident in terms of expected injury and death, may lead people to drive with less caution, resulting in injuries to no occupants and increased nonfatal crashes, which may offset some of the benefits of seatbelt use [2].

When the prevalence of an illness rises, prevalence-dependent behaviour introduces a significant change in how people respond. If behaviour is exogenous, or if behavioural responses are believed to be inelastic in relation to illness prevalence, the susceptible population's per capita risk of infection rises as disease prevalence rises. When behaviour is endogenous and elastic, however, hosts can take steps to lower their risks. They can reduce the average per capita risk and offset the increased risk of transmission associated with increasing prevalence if their reactions are strong enough [3-6].

Alternatively, a decrease in perceived danger, whether due to a decrease in prevalence or the introduction of a vaccine, could lead to an increase in risky behaviour. Models suggested, for example, that the introduction of highly active antiretroviral therapy (HAART), which lowered the morbidity and mortality associated with HIV/AIDS, could lead to an increase in the prevalence of HIV as the perceived risk of HIV/AIDS dropped [7].

None

None

1. d’Onofrio A, Manfredi P (2009) Information-related changes in contact patterns may trigger oscillations in the endemic prevalence of infectious diseases. J Theor Biol 256(3):473-478.

Indexed at, Google Scholar, Cross ref

2. Peltzman S (1975) the effects of automobile safety regulation. J Polit Econ 83(4):677-725.

Indexed at, Google Scholar, Cross ref

3. Blower SM, McLean AR (1994) Prophylactic vaccines, risk behaviour change, and the probability of eradicating HIV in San Francisco. Sci 265(5177):1451-1454.

Indexed at, Google Scholar, Cross ref

4. Blythe SP, Cooke K, Castillo-Chavez C (1991) Autonomous risk-behavior change, and non-linear incidence rate, in models of sexually transmitted diseases.

Google Scholar         

5. Philipson TJ, Posner RA (1993) Private choices and public health: The AIDS epidemic in an economic perspective. Harvard University Press.

Indexed at, Google Scholar                 

6. Klein E, Laxminarayan R, Smith DL, Gilligan CA (2007) Economic incentives and mathematical models of disease. Environment and development economics 12(5):707-732.

Indexed at, Google Scholar, Crossref

7. Blower SM, Gershengorn HB, Grant RM (2000) a tale of two futures: HIV and antiretroviral therapy in San Francisco. Sci 287(5453):650-654.

Indexed at, Google Scholar, Cross ref